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Fasting Might Not Be Necessary Before Lipid Screening:
A Nationally Representative Cross-sectional Study
WHAT’S KNOWN ON THIS SUBJECT: Fasting lipid panels are
recommended to screen for lipid abnormalities; however, fasting
can be difficult for children and make screening difficult. Results
of studies in adult patients are raising questions of whether
fasting is needed before lipid screening.
WHAT THIS STUDY ADDS: In a nationally representative sample
of children, small but likely unimportant differences in lipid panel
results were found between children who had fasted and those
who had not fasted before testing, which indicates that fasting
before lipid screening in children might not be necessary.
abstract
BACKGROUND: There are barriers to fasting lipid screening for at-risk
children. Results of studies in adults have suggested that lipid testing
might be reliably performed without fasting.
OBJECTIVE: To examine population-level differences in pediatric lipid
values based on length of fast before testing.
METHODS: We used the National Health and Nutrition Examination Sur-
vey (1999–2008) to examine total cholesterol (TC), HDL (high-density
lipoprotein), LDL (low-density lipoprotein), and triglyceride cholesterol
components on the basis of the period of fasting. Young children fasted
for varying times before being tested, and children older than 12 years
were asked to fast; however, adherence was variable. We used ordi-
nary least-squares regression to test for differences in lipid values that
were based on fasting times, controlling for weight status, age, race,
ethnicity, and gender.
RESULTS: TC, HDL, LDL, or triglyceride values were available for 12 744
children. Forty-eight percent of the TC and HDL samples and 80% of the
LDL and triglyceride samples were collected from children who had
fasted 8 hours. Fasting had a small positive effect for TC, HDL, and
LDL, resulting in a mean value for the sample that was 2 to 5 mg/dL
higher with a 12-hour fast compared with a no-fast sample. Fasting
time had a negative effect on triglycerides (  0.859; P  .02),
which resulted in values in the fasting group that were 7 mg/dL lower.
DISCUSSION: Comparison of cholesterol screening results for a non-
fasting group of children compared with results for a similar fasting
group resulted in small differences that are likely not clinically impor-
tant. Physicians might be able to decrease the burden of childhood
cholesterol screening by not requiring prescreening fasting for these
components. Pediatrics 2011;128:463–470
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There is heightened concern about the
current and future cardiovascular
health of children and adolescents.
The high prevalence of obesity,1 the
recognition that hyperlipidemia in
childhood has an immediate impact
and might have a long- term impact on
cardiovascular physiology,2–4 and the
increasing number of treatment op-
tions for hyperlipidemia in children5,6
have all led the American Academy of
Pediatrics (AAP) and the American
Heart Association to recommend fast-
ing lipid panel screening for children
as young as 2 years who are at risk for
dyslipidemia.6,7
Screening of children for lipid disor-
ders presents unique challenges. Most
children will not have fasted before a
routine physician office visit.8,9 There-
fore, most fasting lipid panels must be
either planned before visits or
checked at subsequent office visits or
additional visits to outpatient phlebot-
omy centers. These arrangements re-
quire many parents to miss work and
children to miss school to arrive for an
early morning test, and enforcing the
requirement that children fast might
be more difficult and unpleasant than
asking adults to fast. All of these barri-
ers to fasting in children might de-
crease physician and parental adher-
ence to lipid screening guidelines in
children.
Fasting of 8 to 12 hours is recom-
mended before lipid screening be-
cause of the theoretical dynamic
changes that can occur in test results
for some lipid components during a
postprandial test.10 Cholesterol travels
in the blood in 5 major forms: low-
density lipoproteins (LDLs), intermedi-
ate density lipoproteins, high-density
lipoproteins (HDLs), very low-density li-
poproteins (VLDLs), and chylomi-
crons.9,10 Chylomicrons, which are
found after intestinal cells absorb fat-
containing food, and VLDL comprise
the majority of the serum triglyceride
values, and therefore triglycerides
change in response to fasting sta-
tus.9,10 In most clinical laboratories,
the total cholesterol (TC), HDL, and tri-
glyceride levels in standard lipid pan-
els are directly measured, and the LDL
is estimated by use of the Friedewald
calculation (LDL  [TC  HDL]  [tri-
glycerides/5]).11 Since triglycerides
vary according to fasting status, calcu-
lated LDL is also affected.12,13 Because
of the potential impact of eating on tri-
glyceride and LDL values, nonfasting
lipid testing is often used only for mea-
suring TC, HDL, and the difference be-
tween the 2, or non-HDL cholesterol.
Despite the physiologic explanation of
lipid changes related to fasting status,
results of recent research in adults
and children have raised questions re-
garding the importance of fasting be-
fore the measurement. Researchers
have suggested that for the majority of
people who take in an average-size
meal, the overall lipid profiles will have
minimal postprandial change.12,14,15 In
addition, some research in adult pa-
tients has suggested that abnormal
postprandial triglyceride levels might
actually be more highly associated
with cardiovascular disease than ab-
normal fasting levels.16,17 Finally, in re-
ports of studies of both adults and chil-
dren, various authors have questioned
the added value of cardiovascular risk
assessment of LDL cholesterol levels
beyond TC, HDL, and non-HDL choles-
terol levels.18–22
Because of the added burden of fasting
before screening and the emerging re-
search data that call into question the
value of fasting before lipid assess-
ment of cardiovascular risk in adults,
we sought to determine the effect of
fasting on complete lipid panels in chil-
dren. Specifically, we took advantage
of variable fasting times within the na-
tionally representative National Health
and Nutrition Survey (NHANES) to de-
termine if there are differences in TC,
HDL, LDL, and non-HDL cholesterol be-
tween blood samples from fasting and
nonfasting study participants. Second,
if there were important differences,
we sought to understand how these
varied on the basis of length of fast and
the underlying weight status and the
gender of the children. Finally, we
sought to determine if differences in
cholesterol values based on fasting
status would lead to changes in classi-
fication or differences in treatment op-
tions. We hypothesized that there
would be differences in triglyceride
values that were based on fasting sta-
tus, but that subsequent difference in
the calculated LDL value would actually
be minimal, and likely not great
enough to cause a change in interpre-
tation of screening results.
PATIENTS AND METHODS
In this cross-sectional study we took
advantage of the natural experimental
conditions resulting from the variable
fasting times in children before labora-
tory testing in the NHANES 1999–2008
surveys. The NHANES is a stratified, mul-
tistage probability sample of the civilian,
noninstitutionalized population of the
United States. The data-collection pro-
cess includes computer-based inter-
views, an in-home questionnaire on a va-
riety of demographic and health topics,
an examination including a thorough
physical examination with measured
heights and weights, and laboratory
measures.23
Sample
We included children aged 3 to 17
years who had at least 1 of the 4 com-
mon lipidmeasurements available (TC,
HDL, LDL, or triglycerides).
Independent Variables
Fasting Time
All children aged 3 years and older
were eligible for lipid testing and were
evaluated in either a morning or after-
464 STEINER et al
noon session. Children evaluated in
the morning had TC, HDL, LDL, and tri-
glycerides measured; those aged 12
years or older were asked to fast,
whereas those younger than 12 years
were given no specific fasting instruc-
tions. Children evaluated in the after-
noon had TC and HDL measured and
were not given any specific fasting in-
structions regardless of age. Informa-
tion on time since last food or drink
consumed was recorded and available
on all children, regardless of session
time or specific instructions. We ex-
tracted fasting time as reported for
each child, and by taking advantage of
the different fasting instructions and
variable adherence to those instruc-
tions, we examined the relationship
between fasting time and lipid values.
Weight Status
We used height and weight as mea-
sured during the examination compo-
nent to calculate BMI and determine
percentiles by using a SAS code devel-
oped for that purpose (SAS Institute,
Cary, NC).24
Dependent Variables
Equipment used for lipid analyses var-
ied according to year. During 1999–
2004, a Roche Hitachi 704 Analyzer
(Roche Diagnostics, Fishers, IN) was
used; during 2005, a Roche Hitachi 717
was used; during 2006 a Roche Hitachi
912 was used; and during 2007–2008, a
Roche Modular P was used.25
TC was measured enzymatically in se-
rum or plasma for all years.
HDL cholesterol in 1999–2002 was mea-
sured by using heparin-manganese pre-
cipitation or direct immunoassay mea-
surement, depending on sample size
and patient age. Beginning in 2003, all
samples were tested by using a direct
immunoassay. Despite the difference
in laboratorymethods, the changes for
HDL values over the period, compared
with those for the Centers for Disease
Control reference standard were
within the acceptable range, and did
not necessitate additional adjustment
with our focus on fasting-based differ-
ences averaged over the period.25
Triglyceridesweremeasured enzymat-
ically in serum for all years.
LDL was calculated from TC, HDL, and
triglycerides as follows: LDL  (TC 
HDL) (triglycerides/5).
Non-HDL cholesterol was calculated by
subtracting the HDL cholesterol value
from the TC value.
Statistical Methods
We first used ordinary least-squares
regression to test for differences in
lipid values based on fasting times. We
controlled for weight status, race, eth-
nicity, gender, and, because lipid val-
ues differ by age,26 we also controlled
for age, as well as squared and cubic
transformations of age. We used these
equations to predict lipid values based
on fasting time, and graphed mean
lipid values across hours of fasting.
Second, we used seemingly unrelated
regressionmodels to examine if the ef-
fect of fasting time on lipid values var-
ied on the basis of whether the child
was healthy weight or overweight/
obese. Healthy weight was defined as
85th percentile, and overweight and
obese were collapsed at 85th per-
centile for all children.
Finally, using our adjusted equations
and baseline distribution of choles-
terol results in the sample, we calcu-
lated predicted lipid values for groups
of children from the population who
had blood drawn immediately post-
prandially instead of subsequent to an
ideal 12-hour fast.
All analyses were adjusted for the
complex survey design of the NHANES
and were performed by using the sur-
vey estimation routines in Stata 11.0
(Stata Corp, College Station, TX). This
study was deemed exempt from insti-
tutional review board review (under
federal regulation 45 CFR §46.101), be-
cause it included the use of only de-
identified secondary data.
RESULTS
A total of 12 744 children aged 3 to 17
years had values for at least 1 of the 4
lipid components. The mean age was
11 years, most of the children were
healthy weight (64%), and the fewest
children were in the age range of 3 to 5
years because starting in 2006 the
NHANES measured lipid values only for
children older than 5 years. Triglycer-
ides and LDL results from morning
blood tests were available for 38.6%
and 37.5% of the sample, respectively,
and with the use of AAP cutoffs, mea-
sured values were normal for 63% of
TC values, 95% of HDL, 79% of LDL, and
97% of triglyceride values. Nearly half
(48%) of the TC and HDL samples were
obtained from childrenwho had fasted
for at least 8 hours, and 80% of the LDL
and triglyceride sample was from chil-
dren who had fasted for at least 8
hours (Table 1).
The data in Table 2 demonstrate the
mean difference in each lipid compo-
nent measurement per hour of fasting
status. After adjustment for subject
age, weight status, self-identified race/
ethnicity, and gender, there were only
small changes in lipid components
based on hours of fasting, although
values for all measurands except non-
HDL cholesterol did reach statistical
significance. For example, for each
hour of fasting, the TC increased by an
average of 0.17mg/dL (P .05). Stated
another way, if an average child were
screened immediately postprandially,
his or her TC would be2mg/dL lower
than another average child after a 12-
hour fast. These results are displayed
graphically in Fig 1. The peak mean
cholesterol values appear at fasting
times of5 and 14 hours, with a min-
imum value at10 hours of fasting.
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The LDL cholesterol increased in the ad-
justed model by 0.46 mg/dL per hour of
fasting (Table 2). Again, the LDL of an
average child would be 5 mg/dL
lower immediately postprandially
compared with the LDL subsequent to
a 12-hour fast. Figure 2 displays the
averaged LDL cholesterol values in
children who had fasted for varying
amounts of time. This line has a gener-
ally linear increase over time that
peaks at 15 hours of fasting. The calcu-
lated LDL change graphed over time
seems to be the inverse of the triglyc-
eride graph, which decreases in a lin-
ear fashion over time. The HDL choles-
terol increases by an average of 0.08
mg/dL per hour (Fig 3). The graph of
the HDL cholesterol over time does
not demonstrate clinically important
change, and because the TC is also rel-
atively stable, the calculated non-HDL
cholesterol does not show a dramatic
change over time (Fig 3).
Overweight children had slightly in-
creased mean changes in lipid compo-
nents per hour of fasting compared
with healthy weight children. However,
the degree of these changes was still
small relative to overall lipid value re-
sults, and there were no statistically
significant differences when the
changes in cholesterol values accord-
ing to weight status were compared
(Table 3). The age of the child at time of
screening did not have a consistent im-
pact on the response to fasting time of
the cholesterol result (Table 4).
Effect of Fasting on Lipid
Classification
For TC, nonfasting screening inappro-
priately classifies 1% of children as
normal, who would have had border-
line values with fasting. In addition,
1% of children with borderline non-
fasting values would actually have ele-
vated results if fasting. For LDL, 1.2% of
children with borderline fasting levels
would have normal results postprandi-
ally, and 1.6% of children with in-
creased calculated LDL while fasting,
would now be considered to have bor-
derline results. For triglycerides,4%
of the children classified with normal
triglycerides when fasting would have
elevated values postprandially.
TABLE 2 Ordinary Least-Squares Regression of the Effect of Number of Hours (Continuous) on










Cholesterol 0.033 .669 0.120 to 0.186 0.174a .048a 0.002 to 0.346a
HDL 0.034 .179 0.016 to 0.085 0.078a .007a 0.022 to 0.133a
Non-HDL 0.001 .992 0.156 to 0.154 0.097 .271 0.077 to 0.270
LDL 0.243 .115 0.061 to 0.548 0.456a .013a 0.099 to 0.813a
Triglycerides 0.664a .022a 1.229 to0.100a 0.859a .019a 1.573 to0.144a
a Statistically significant effects.
FIGURE 1
Predicted values of TC based on hours of fasting before testing.
TABLE 1 Demographic and Mean










Age, mean (range), y 11.02 (3–17)
3–5 y, % 9.4
6–8 y, % 20.5
9–11 y, % 22.0
12–14 y, % 23.8
15–17 y, % 24.3
Weight status (percentile), %
Very obese (99th) 4.0
Obese (95th–99th) 13.1
Overweight (85th–95th) 15.8





















Total fasting time, mean
(range), h
6.9 (0–180)
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DISCUSSION
Comparing a nationally representative
cross-section of children who had
fasted for various lengths of time, we
demonstrated that nonfasting mea-
surements of TC, calculated LDL, and
HDL cholesterol values had only small
differences from fasting values. Al-
though statistically significant, these
differences are unlikely to result in im-
portant clinical changes in the results
of screening for cholesterol abnormal-
ities. Triglyceride values differed more
dramatically on the basis of fasting
status. The weight status and age of
subjects within the sample did not con-
sistently affect the variation based on
fasting status.
Previous studies in adult patients have
also documented minimal differences
in lipoprotein profiles after normal
food intake in the general population.12
In fact, a recent study by Langsted et al
in adults found that when LDL samples
were corrected for the hemodilution
that occurred with fasting while un-
sweetened fluid intakewas allowed, di-
rectly measured LDL did not change
with fasting.14 The differences of cho-
lesterol values in our sample based on
fasting status are actually smaller
than other causes of variation not ac-
counted for in the current screening
guidelines. A recent study revealed
large variations in fasting LDL choles-
terol over time in children.27 These dif-
ferences could cause clinically impor-
tant changes in diagnosis and
treatment. For example, up to 1 in 3
children with elevated LDL levels at 10
years of age will have normal-range
levels 3 years later.27 The changes in
cholesterol values over time have also
been studied in relation to retesting of
adult patients with normal and abnor-
mal baseline cholesterol values. In
these subjects, coefficients of varia-
tion for results of retests within a per-
son over time ranged between 6% and
11% for the various cholesterol com-
ponents.28,29 For adult patients with el-
evated TC, this would result in individ-
ual variation with an SD of between 15
and 23 mg/dL.29 Although the testing
procedure we used was different, and
the variation in our study was across a
sample instead of within a person, the
change in mean values based on fast-
ing status is likely less important clin-
ically than longitudinal changes over
time or even than test-retest variation.
Although studies on nonfasting lipids
generally assume that fasting choles-
terol levels are the gold standard to
which other testing strategies should
be compared, research results in
adult patients suggest that nonfasting
lipid panels also predict, and might
even better predict, cardiovascular
disease.12,15 It is particularly notewor-
thy that nonfasting triglycerides in
adult patients are a risk factor for future
myocardial infarction and death,16 and
that nonfasting triglyceridesmight actu-
ally better predict cardiovascular events
in some populations do than fasting val-
ues.17 In children and young adults, fast-
ing values continue to be used for epide-
miologic research,2,3,30–33 although the
FIGURE 2
Predicted values of LDL cholesterol and triglycerides based on hours of fasting before testing.
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degree to which fasting improves risk
prediction in children is questionable.
For example, Frontini et al analyzed the
predictive values of non-HDL choles-
terol of children in the Bogalusa Heart
Study database. Non-HDL cholesterol
does not change with fasting status,
and Frontini et al determined that
it predicted future cardiovascular
events as well as other lipoprotein
measurements.20
The major limitation of our research
was that all analyses were conducted
across a large sample and on a cross-
sectional basis. We were not able to
analyze the cholesterol results from
an individual child repeatedly after
various periods of fasting. Although
our research allows us to confidently
demonstrate the population-level dif-
ferences in cholesterol values at vari-
ous periods of time after eating, we
assume that some children will have
greater or less dramatic differences in
fasting and nonfasting values. For ex-
ample, although not statistically differ-
ent, values for obese children had a
trend toward more dramatic lipid re-
sult changeswith fasting. In addition, it
is possible that there was a systematic
difference within our sample between
children who fasted and children who
did not fast before testing. We did con-
trol for weight status, which should
mitigate 1 risk for unmeasured sys-
tematic differences associated with
which of the children fasted, but there
might be others. A third limitation of
our work was that all of our LDL cho-
lesterol values were calculated values
determined by use of the Freidewald
equation used in the NHANES.11 Directly
measured LDL values are increasingly
being used in clinical laboratories, and
studies comparing directly measured
LDL to calculated LDL after various
fasting times in children are war-
ranted. However, in previous work
with adult patients, directly measured
and calculated fasting LDL values were
similar and equally predicted future
cardiovascular events.34
The AAP currently recommends a fast-
ing lipid panel on any child or adoles-
cent with an increased risk of hyperlip-
idemia or other cardiovascular risk
FIGURE 3
Predicted values of HDL and non-HDL cholesterol based on hours of fasting before testing.
TABLE 3 Effect of Fasting Time (in Hours) on TC, HDL, LDL, and Triglycerides According to Weight
Status After Adjustment for Age, Race, and Gender






Cholesterol 0.089 0.102 to 0.279 0.292 0.029 to 0.555 .163
HDL 0.054 0.016 to 0.124 0.107 0.020 to 0.194 .336
Non-HDL 0.035 0.155 to 0.225 0.185 0.079 to 0.449 .299
LDL 0.360 0.054 to 0.775 0.688 0.224 to 1.152 .223
Triglycerides 0.970 1.705 to0.234 0.717 1.726 to 0.292 .656
a P value for the difference between coefficients in the healthy weight and overweight regressions.
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factors.6 However, preparing for the
fasting state makes screening recom-
mendationsmore burdensome. In fact,
although no formal cost analyses has
been done, the fasting requirement
likely makes the screening process
more expensive because of the need
for return office visits, increased
transportation expenses, and missed
work and/or school. This increased
burden and cost are not only likely to
undermine appropriate screening, but
also potentially worsens the utility of
screening in any formal cost analysis.
Because research findings in other
populations suggest that nonfasting
lipid panels can predict cardiovascu-
lar events, and that the difference be-
tween fasting and nonfasting lipid pan-
els in children is small and likely
clinically insignificant, the risks of
missed screening or increased
screening cost as a result of recom-
mending fasting status raise ques-
tions regarding any benefits achieved.
CONCLUSIONS
Across a large, nationally representa-
tive sample of children, the levels of TC,
HDL, non-HDL cholesterol, and LDL cho-
lesterol vary minimally on the basis of
fasting time. It is not known if these
small differences in lipoprotein com-
ponents consistently weaken or
strengthen the usefulness of lipid val-
ues for the assessment of current
health risks or prediction of future
cardiovascular risks, but it is clear
that testing regardless of fasting sta-
tus would reduce barriers to screen-
ing. Therefore, future research with
people in longitudinal samples is
warranted. If those results confirm
our findings, professional societies
might wish to reconsider their rec-
ommendations and encourage pro-
viders follow lipid screening guide-
lines at the point of care, regardless
of fasting status.
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